“We at HL believe that all people should get the best quality medicines. We endeavour to restore them to health.”
HL formulates pharmaceutical tablets which contain precise amount of active pharmaceutical ingredients (APIs) along with excipients such as binders, lubricants, colours, flavours, disintegrants, anti-adherants, coaters etc. Tablets are the most commonly used dosage forms. Ease of administration, accurate dosing and stability has made it a popular and versatile dosage form.
Tablet is formed after the compression stage. Three different techniques are used for the preparation of mix: direct compression, dry granulation, or wet granulation. The pathway used depends on what is needed to do to make a tablet out of an active ingredient. The quality of a tablet is checked for good weight thickness and hardness control, no capping, no lamination, no sticking, good friability, good disintegration and good dissolution.
Capsules are solid dosage forms in which one or more active pharmaceutical ingredient (API) and excipients are enclosed in a small shell or container usually made of gelatin. HL formulates hard gelatin capsules. The advantages of capsules: masks unpleasant taste of the drug, easy to swallow, rapid release of the drug, elegance, easy to store and transport, and longer shelf life. Quality control tests are performed such as purity of raw materials, content uniformity, weight variation, disintegration, dissolution, moisture content etc.
We manufacture Oral Powders which are made up of dry powders meant for oral administration. Oral powders are preparations consisting of solid, loose, dry particles of varying degrees of fineness. They contain one or more active ingredients, with or without excipients and, if necessary, authorized colouring matter and flavouring substances. They are generally administered in or with water or another suitable liquid. They may also be swallowed directly. They are presented as single-dose or multidose preparations. The prime means to counteract segregation is to use components of approximately the same particle size. Because of the risk of segregation, oral powders containing a low proportion of the active ingredient, say less than 5 % of total mass, should preferably be prepared as single-dose preparations.